Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. (Q51293603)
Jump to navigation
Jump to search
scientific article published on 25 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. |
scientific article published on 25 November 2015 |
Statements
1 reference
Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. (English)
1 reference
1 reference
Sony S Thazhath
1 reference
Tongzhi Wu
1 reference
Michelle J Bound
1 reference
Helen L Checklin
1 reference
Scott Standfield
1 reference
Michael Horowitz
1 reference
Christopher K Rayner
1 reference
25 November 2015
1 reference
103
1 reference
1
1 reference
66-70
1 reference
Identifiers
1 reference